AVEO
AVEO Pharmaceuticals, Inc.
AVEO
AVEO
Delisted
AVEO was delisted on the 19th of January, 2023.
58 hedge funds and large institutions have $72.3M invested in AVEO Pharmaceuticals, Inc. in 2021 Q4 according to their latest regulatory filings, with 12 funds opening new positions, 14 increasing their positions, 16 reducing their positions, and 6 closing their positions.
New
Increased
Maintained
Reduced
Closed
more first-time investments, than exits
New positions opened: | Existing positions closed:
more call options, than puts
Call options by funds: $ | Put options by funds: $
more funds holding
Funds holding: →
less repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
22% less capital invested
Capital invested by funds: $92.7M → $72.3M (-$20.4M)
Holders
58
Holding in Top 10
1
Calls
$2.75M
Puts
$1.39M
Top Buyers
| 1 | +$2.68M | |
| 2 | +$932K | |
| 3 | +$613K | |
| 4 |
BC
Birchview Capital
Burlington,
Vermont
|
+$469K |
| 5 |
Citadel Advisors
Miami,
Florida
|
+$303K |
Top Sellers
| 1 | -$2.08M | |
| 2 | -$901K | |
| 3 | -$218K | |
| 4 |
CSS
Cubist Systematic Strategies
Stamford,
Connecticut
|
-$207K |
| 5 |
Morgan Stanley
New York
|
-$187K |